1 |
Sorg AL, Hufnagel M, Doenhardt M, Diffloth N, Schroten H, von Kries R, et al. Risk of hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany. medRxiv, in press 2021.
|
2 |
Yang H; Food and Drug Administration, Vaccines and Related Biological Products Advisory Committee. Benefits-risks of Pfizer-BioNTech COVID-19 vaccine for ages 5 to 11 years [Internet]. Silver Spring (MD): Food and Drug Administration; 2021 [cited 2022 Mar 31]. Available from: https://www.fda.gov/media/153507/download.
|
3 |
Infectious Diseases Society of America, Pediatric Infectious Diseases Society. IDSA and PIDS support authorization of pediatric COVID-19 vaccine [Internet]. Arlington (VA): Infectious Diseases Society of America; 2021 [cited 2022 Jan 6]. Available from: https://www.idsociety.org/news--publications-new/articles/2021/idsa-and-pids-support-authorization-of-pediatric-covid-19-vaccine/.
|
4 |
Su JR. COVID-19 vaccine safety updates: Primary series in children and adolescents ages 5-11 and 12-15 years, and booster doses in adolescents ages 16-24 years [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2022 [cited 2022 Mar 31]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-01-05/02-covid-su-508.pdf.
|
5 |
Hause AM, Baggs J, Marquez P, Myers TR, Gee J, Su JR, et al. COVID-19 vaccine safety in children aged 5-11 years - United States, November 3-December 19, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1755-60.
DOI
|
6 |
American Academy of Pediatrics. Children and COVID-19 vaccination trends [Internet]. Itasca (IL): American Academy of Pediatrics; 2022 [cited 2022 Mar 31]. Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-vaccination-trends/.
|
7 |
Australian Technical Advisory Group on Immunisation. ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years [Internet]. Canberra: Australian Technical Advisory Group on Immunisation; 2022 [cited 2022 Mar 31]. Available from: https://www.health.gov.au/news/atagi-recommendations-on-the-use-of-spikevax-moderna-covid-19-vaccine-in-children-aged-6-to-11-years.
|
8 |
Australian Technical Advisory Group on Immunisation. ATAGI recommendations on Pfizer COVID-19 vaccine use in children aged 5 to 11 years [Internet]. Canberra: Australian Technical Advisory Group on Immunisation; 2021 [cited 2022 Jan 22]. Available from: https://www.health.gov.au/resources/publications/atagi-recommendations-on-pfizer-covid-19-vaccine-use-in-children-aged-5-to-11-years.
|
9 |
Woodworth KR, Moulia D, Collins JP, Hadler SC, Jones JM, Reddy SC, et al. The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years - United States, November 2021. MMWR Morb Mortal Wkly Rep 2021;70:1579-83.
DOI
|
10 |
Committee on Infectious Diseases. COVID-19 vaccines in children and adolescents. Pediatrics 2022;149:e2021054332.
DOI
|
11 |
Health Sciences Authority. HSA extends the use of comirnaty COVID-19 vaccine by Pfizer-BioNTech to children of ages 5 to 11 [Internet]. Singapore: Health Sciences Authority; 2022 [cited 2022 Mar 31]. Available from: https://www.hsa.gov.sg/announcements/press-release/pfizercomirnaty_children.
|
12 |
Ministry of Health. Preparing for the Omicron variant [Internet]. Singapore: Ministry of Health; 2021 [cited 2022 Mar 31]. Available from: https://www.moh.gov.sg/news-highlights/details/preparing-for-the-omicron-variant_14Dec2021.
|
13 |
Ministry of Health. Expert Committee on COVID-19 Vaccination Recommends using the paediatric dose Pfizer-BioNTech/Comirnaty vaccine for children aged 5-11 years and extending booster vaccination to persons aged under 30 years [Internet]. Singapore: Ministry of Health; 2021 [cited 2022 Mar 31]. Available from: https://www.moh.gov.sg/news-highlights/details/expert-committee-on-covid-19-vaccination-recommends-using-the-paediatric-dose-pfizer-biontech-comirnaty-vaccine-for-children-aged-5-11-years-and-extending-booster-vaccination-to-persons-aged-under-30-years.
|
14 |
Ministry of Health. Vaccination statistics [Internet]. Singapore: Ministry of Health; 2021 [cited 2022 Mar 31]. Available from: https://www.moh.gov.sg/covid-19/vaccination/statistics.
|
15 |
Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020;26:1200-4.
DOI
|
16 |
Forrest CB, Burrows EK, Mejias A, Razzaghi H, Christakis D, Jhaveri R, et al. Severity of acute COVID-19 in children <18 years old March 2020 to December 2021. Pediatrics 2022;149:e2021055765.
DOI
|
17 |
Lee H, Choi S, Park JY, Jo DS, Choi UY, Lee H, et al. Analysis of critical COVID-19 cases among children in Korea. J Korean Med Sci 2022;37:e13.
DOI
|
18 |
Korea Disease Control and Prevention Agency. COVID-19 vaccination guide - for children 5-11 years old [Internet]. Cheongju: Korea Disease Control and Prevention Agency; 2022 [cited 2022 Mar 31]. Available from: https://ncv.kdca.go.kr/filepath/boardDownload.es?bid=0031&list_no=730&seq=1.
|
19 |
Ministere des Solidarites et de la Sante. Le tableau de bord de la vaccination [Internet]. Paris: Ministere des Solidarites et de la Sante; 2021 [cited 2022 Mar 31]. Available from: https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/le-tableau-de-bord-de-la-vaccination.
|
20 |
U.K. Joint Committee on Vaccination and Immunisation. JCVI statement on COVID-19 vaccination of children and young people: 22 December 2021 [Internet]. [place unknown]: U.K. Joint Committee on Vaccination and Immunisation; 2021 [cited 2022 Jan 19]. Available from: https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-and-young-people/jcvi-statement-on-covid-19-vaccination-of-children-and-young-people-22-december-2021.
|
21 |
U.K. Joint Committee on Vaccination and Immunisation. JCVI statement on vaccination of children aged 5 to 11 years old [Internet]. [place unknown]: U.K. Joint Committee on Vaccination and Immunisation; 2022 [cited 2022 Mar 31]. Available from: https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-aged-5-to-11/jcvi-statement-on-vaccination-of-children-aged-5-to-11-years-old.
|
22 |
COVID-19 Clinical Information Network. CO-CIN: child admissions and severity by epoch CO-CIN update January 2022, 6 January 2022 [Internet]. [place unknown]: COVID-19 Clinical Information Network; 2022 [cited 2022 Feb 26]. Available from: https://www.gov.uk/government/publications/co-cin-child-admissions-and-severity-by-epoch-co-cin-update-january-2022-6-january-2022.
|
23 |
Scientific Committee on Vaccine Preventable Diseases. Consensus interim recommendations on the use of COVID-19 vaccines in children in Hong Kong (As of 17 January 2022) [Internet]. Hong Kong: Centre for Health Protection; 2022 [cited 2022 Mar 31]. Available from: https://www.chp.gov.hk/files/pdf/consensus_interim_recommendations_on_the_use_of_covid_19_vaccines_in_children_in_hong_kong_17jan.pdf.
|
24 |
Scientific Committee on Vaccine Preventable Diseases. Consensus interim recommendations on the use of COVID-19 vaccines in Hong Kong (As of 25 February 2022)(Updated on 12 Mar 2022) [Internet]. Hong Kong: Centre for Health Protection; 2022 [cited 2022 Mar 31]. Available from: https://www.chp.gov.hk/files/pdf/consensus_interim_recommendations_on_the_use_of_covid19_vaccines_in_hong_kong_25feb_updated_on_12mar.pdf.
|
25 |
Pharmaceuticals and Medical Devices Agency. Report on special approval [Internet]. Tokyo: Pharmaceuticals and Medical Devices Agency; 2022. Available from: https://www.pmda.go.jp/drugs/2022/P20220117002/672212000_30400AMX00015000_A100_2.pdf.
|
26 |
The Government of Hong Kong SAR. Hong Kong vaccination dashboard [Internet]. Hong Kong: The Government of Hong Kong SAR; 2022 [cited 2022 Mar 31]. Available from: https://www.covidvaccine.gov.hk/en/.
|
27 |
Pharmaceuticals and Medical Devices Agency. PMDA's efforts to combat COVID-19 [Internet]. Tokyo: Pharmaceuticals and Medical Devices Agency; 2021 [cited 2022 Mar 31]. Available from: https://www.pmda.go.jp/english/about-pmda/0002.html.
|
28 |
Nakano T. Effects of the novel coronavirus vaccine on children aged 5 to 11 years [Internet]. Tokyo: Ministry of Health, Labour and Welfare; 2022 [cited 2022 Mar 31]. Available from: https://www.cov19-vaccine.mhlw.go.jp/qa/column/0012.html.
|
29 |
Yi-ching C. Taiwan to hold off vaccinating 5-11-year-olds against COVID-19. Focus Taiwan [Internet]. 2022 Mar 24 [cited 2022 Mar 31]; Society. Available from: https://focustaiwan.tw/society/202203240016.
|
30 |
Cabinet Public Relations Office. COVID-19 vaccines [Internet]. Tokyo: Cabinet Public Affairs Office; 2021 [cited 2022 Mar 31]. Available from: https://japan.kantei.go.jp/ongoingtopics/vaccine.html.
|
31 |
Ministry of Health and Welfare. Coronavirus (COVID-19), Republic of Korea [Internet]. Sejong: Ministry of Health and Welfare; 2022 [cited 2022 Mar 31]. Available from: http://ncov.mohw.go.kr/.
|
32 |
Mensah AA, Campbell H, Stowe J, Seghezzo G, Simmons R, Lacy J, et al. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England. Lancet Child Adolesc Health, in press 2022.
DOI
|
33 |
Levy M, Recher M, Hubert H, Javouhey E, Flechelles O, Leteurtre S, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA 2022;327:281-3.
DOI
|
34 |
McDade TW, Sancilio A, D'Aquila R, Mustanski B, Vaught LA, Reiser NL, et al. Low levels of neutralizing antibodies after natural infection with severe acute respiratory syndrome coronavirus 2 in a communitybased serological study. Open Forum Infect Dis 2022;9:ofac055.
DOI
|
35 |
Dorabawila V, Hoefer D, Bauer UE, Bassett MT, Lutterloh E, Rosenberg ES. Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant. medRxiv, in press 2022.
|
36 |
Klein NP, Stockwell MS, Demarco M, Gaglani M, Kharbanda AB, Irving SA, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:352-8.
DOI
|
37 |
U.K. Cabinet Office. COVID-19 response: living with COVID-19 [Internet]. London: U.K. Cabinet Office; 2022. Available from: https://www.gov.uk/government/publications/covid-19-response-living-with-covid-19/covid-19-response-living-with-covid-19.
|
38 |
AusVaxSafety. Pfizer COVID-19 vaccine safety data - child participants [Internet]. Westmead: AusVaxSafety; 2021 [cited 2022 Jan 23]. Available from: https://ausvaxsafety.org.au/covid-19-vaccines/child-participants.
|
39 |
European Medicines Agency. Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 [Internet]. Amsterdam: European Medicines Agency; 2021 [cited 2022 Mar 31]. Available from: https://www.ema.europa.eu/en/news/comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11.
|
40 |
Scientific Committee on Vaccine Preventable Diseases. Consensus interim recommendations on the use of COVID-19 vaccines in persons with previous COVID-19 infection and children in Hong Kong (as of 12 March 2022) [Internet]. Hong Kong: Centre for Health Protection; 2022 [cited 2022 Mar 31]. Available from: https://www.chp.gov.hk/files/pdf/consensus_interim_recommendations_on_the_use_of_covid19_vaccines_in_persons_with_previous_covid19_infection_and_children_in_hong_kong_12mar.pdf.
|
41 |
Agenzia Italiana del Farmaco. AIFA approves Comirnaty vaccine for ages 5 to 11 [Internet]. Roma: Agenzia Italiana del Farmaco; 2021 [cited 2022 Mar 31]. Available from: https://www.aifa.gov.it/documents/20142/1289678/Comunicato_AIFA_674_EN.pdf.
|
42 |
Esposito S; Pediatricians of Emilia-Romagna Region, Italy. Manifesto of the pediatricians of Emilia-Romagna region, Italy, in favor of vaccination against COVID in children 5-11 years old. Ital J Pediatr 2022;48:40.
DOI
|
43 |
Presidenza del Consiglio dei Ministri; Unita Completamento Campagna Vaccinale; Ministero della Salute. Report vaccini anti COVID-19 [Internet]. Rome: Presidenza del Consiglio dei Ministri; 2022 [cited 2022 Apr 1]. Available from: https://www.governo.it/it/cscovid19/report-vaccini/.
|
44 |
Vygen-Bonnet S, Koch J, Armann J, Berner R, Bogdan C, Burchard G, et al. STIKO-Empfehlung zur COVID-19-Impfung von Kindern im alter von 5-11 Jahren mit dem mRNA-impfstoff comirnaty und die dazugehorige wissenschaftliche Begrundung. Epidemiol Bull 2022;1:16-47.
|
45 |
Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, et al. Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes. medRxiv, in press 2022.
|
46 |
European Centre for Disease Prevention and Control. Interim public health considerations for COVID-19 vaccination of children aged 5-11 years [Internet]. Solna: European Centre for Disease Prevention and Control; 2021 [cited 2022 Mar 31]. Available from: https://www.ecdc.europa.eu/en/publications-data/interim-public-health-considerations-covid-19-vaccination-children-aged-5-11.
|
47 |
Paul Ehrlich Institute. Verdachtsfalle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19 seit Beginn der Impfkampagne am 27.12.2020 bis zum 31.12.2021 [Internet]. Langen: Paul Ehrlich Institute; 2022 [cited 2022 Mar 28]. Available from: https://www.pei.de/SharedDocs/Downloads/DE/newsroom/dossiers/sicherheitsberichte/sicherheitsbericht-27-12-20-bis-31-12-21.pdf?__blob=publicationFile&v=5.
|
48 |
Bundesministerium fur Gesundheit. Aktueller impfstatus [Internet]. Berlin: Bundesministerium fur Gesundheit; 2022 [cited 2022 Mar 31]. Available from: https://impfdashboard.de/.
|
49 |
Haute Autorite de Sante. Strategie de vaccination contre la Covid-19 - Place du vaccin a ARNm COMIRNATY® chez les 5-11 ans [Internet]. Saint-Denis: Haute Autorite de Sante; 2021 [cited 2022 Mar 31]. Available from: https://www.has-sante.fr/jcms/p_3306504/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-a-arnm-comirnaty-chez-les-5-11-ans.
|
50 |
Ministere des Solidarites et de la Sante. Foire aux questions: la vaccination des enfants [Internet]. Paris: Ministere des Solidarites et de la Sante; 2021 [cited 2022 Mar 31]. Available from: https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/je-suis-un-particulier/la-vaccination-des-enfants.
|
51 |
Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep 2022;71:52-8.
DOI
|